Penn Medicine

The University of Pennsylvania’s Perelman School of Medicine (PSOM) today announced that it will no longer submit data for participation in the U.S. News and World Report (USNWR) annual “Best Medical Schools” rankings.The decision was…

Electronic nudges delivered to health care clinicians based on a machine learning algorithm that predicts mortality risk quadrupled rates of conversations with patients about their end-of-life care preferences, according to the long-term…

Penn Medicine has partnered with the Howley Foundation and La Salle University to launch the ASPIRE Program at the Hospital of the University of Pennsylvania (HUP), marking an important investment in the future of nursing. The high school…

Penn Medicine has received a $9.7 million grant from The Warren Alpert Foundation (WAF) that will fund continuing education efforts for genetic counselors, to ensure opportunities for continued training that will keep them on the leading…

Researchers at Penn Medicine and Intel Corporation led the largest-to-date global machine learning effort to securely aggregate knowledge from brain scans of 6,314 glioblastoma (GBM) patients at 71 sites around the globe and develop a…

Installing new doors and windows, trash cleanup, and weeding at abandoned houses in Philadelphia led to substantial drops in nearby gun violence, according to a new study from the Perelman School of Medicine and School of Arts and…

A small molecule inhibitor that attacks the difficult to target, cancer-causing gene mutation KRAS, found in nearly 30 percent of all human tumors, successfully shrunk tumors or stopped cancer growth in preclinical models of pancreatic…

A gift of over $1 million to the University of Pennsylvania’s Perelman School of Medicine from Harris Philanthropies, Josh Harris, W’86, and Marjorie Harris, will bolster efforts to recruit applicants from diverse backgrounds — and…

Researchers from the University of Pennsylvania’s Abramson Cancer Center presented preliminary results of an ongoing Phase I clinical trial demonstrating successful re-treatment with CAR T cell therapy for patients whose cancers relapsed…

A first-of-its-kind drug known as modakafusp alfa has shown early potential in combating multiple myeloma, a form of bone marrow cancer, in a study presented by researchers from the University of Pennsylvania’s Abramson Cancer Center at…